Changes in Neisseria meningitidis Disease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease

Cohn, Amanda C., MacNeil, Jessica R., Harrison, Lee H., Hatcher, Cynthia, Theodore, Jordan, Schmidt, Mark, Pondo, Tracy, Arnold, Kathryn E. +15 more·2010·Clinical Infectious Diseases
DOI 10.1086/649209

Cited by (345)

Items 201–300 of 345

  1. Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine
    Shannon L. Harris, Cuiwen Tan, John L. Perez, David R. Radley, Kathrin Ute Jansen, Annaliesa S. Anderson, Thomas R. Jones · 2020 · npj Vaccines
  2. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003–2016
    Susan T. Meiring, Cheryl Cohen, Linda de Gouveia, Mignon du Plessis, Ranmini S. Kularatne, Anwar Ahmed Hoosen, Ruth Lekalakala, Sarona Lengana, Sharona Seetharam, Preneshni R. Naicker et al. · 2018 · Clinical Infectious Diseases
  3. Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults
    Lene Fogt Lundbo, Zitta Barrella Harboe, Håkon Sandholdt, Lars Smith‐Hansen, Palle Valentiner‐Branth, Steen Hoffmann, Thomas Benfield · 2021 · Clinical Infectious Diseases
  4. An unwanted guest:Neisseria meningitidis– carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence
    Elena Gianchecchi, Giulia Piccini, Alessandro Torelli, Rino Rappuoli, Emanuele Montomoli · 2017 · Expert Review of Anti-infective Therapy
  5. Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
    Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark W. Cutler, Ping Li, John L. Perez · 2020 · Human Vaccines & Immunotherapeutics
  6. Meningococcal Meningitis
    Ricardo Garcia Branco, Robert Charles Tasker · 2010 · Current Treatment Options in Neurology
  7. The Burden of Infant Meningococcal Disease in the United States
    Richard G. Judelsohn, Gary S. Marshall · 2012 · Journal of the Pediatric Infectious Diseases Society
  8. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain
    Javier Díez‐Domingo, Alejandra Gurtman, Enrique Bernaola, Francisco Giménez‐Sánchez, Federico Martinón‐Torres, Valentín Pineda Solas, Alfonso Delgado, Pilar Infante Marquez, John Z. Liang, Peter C. Giardina et al. · 2013 · Vaccine
  9. Meningococcal vaccines
    Dan M. Granoff, Stephen I. Pelton, Lee H. Harrison · 2013 · Elsevier eBooks
  10. Delays in Diagnosis and Treatment of Bacterial Meningitis in NYC: Retrospective Cohort Analysis
    Sarah D. Torres, Carla Y. Kim, Mitashee Das, Jyoti V. Ankam, Nicole Luche, Michael Harmon, Emily M. Schorr, Brittany Glassberg, Stephen S. Morse, Don Weiss et al. · 2021 · The Neurohospitalist
  11. Meningococcal disease from the public health policy perspective
    STEVEN B. BLACK, Stanley Alan Plotkin · 2012 · Vaccine
  12. Serogroup-Specific Interaction of Neisseria meningitidis Capsular Polysaccharide with Host Cell Microtubules and Effects on Tubulin Polymerization
    Adelfia Talà, Laura Cogli, Mario De Stefano, Marcella Cammarota, Maria Rita Spinosa, Cecilia Bucci, Pietro Alifano · 2013 · Infection and Immunity
  13. The β-reducing end in α(2–8)-polysialic acid constitutes a unique structural motif
    Hugo F. Azurmendi, Marcos D. Battistel, Jasmin S. Zarb, Flora Lichaa, Alejandro Negrete Virgen, Joseph Shiloach, Darón I. Freedberg · 2017 · Glycobiology
  14. Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989–2010)
    Shalom Ben‐Shimol, Ron Dagan, Yochai Schonmann, Noga Givon‐Lavi, N Keller, Colin Block, Imad Kassis, Moshe A. Ephros, Dan Greenberg · 2013 · Infection
  15. Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults
    Martin Alberer, Gerd Dieter Burchard, Tomáš Jelı́nek, Emil Christian Reisinger, Seetha Meyer, Eduardo Forleo‐Neto, Alemnew F. Dagnew, Ashwani Kumar Arora · 2014 · Journal of Travel Medicine
  16. Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae–N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy
    Michael L. Leonardi, Thomas Latiolais, Kwabena O. Sarpong, Michael W. Simon, Jerry D. Twiggs, Paul Lei, Stephen B. Rinderknecht, Mark M. Blatter, Véronique Bianco, Yaela Baine et al. · 2014 · Vaccine
  17. Safety and immunogenicity of meningococcal ACWY CRM197-conjugate vaccine in children, adolescents and adults in Russia
    N I Ilyina, Харит Сусанна Михайловна, Leyla Seymurovna Namazova-Baranova, Asmik Asatryan, Mayya Benashvili, Elmira Tkhostova, Chiranjiwi Bhusal, Ashwani Kumar Arora · 2014 · Human Vaccines & Immunotherapeutics
  18. Etiology of bacterial meningitis: a cross-sectional study among patients admitted in a semi-urban hospital in Nairobi, Kenya
    Charles Njonjo Gituro, Andrew Kimang’a Nyerere, Musa Otieno Ngayo, Edward N Maina, Jane Njoki Githuku, Waqo Gufu Boru · 2017 · Pan African Medical Journal
  19. Meningococcal vaccination in pregnancy
    Bahaa Abu Raya, Manish Sadarangani · 2018 · Human Vaccines & Immunotherapeutics
  20. Emergency Department Presentation of Children With Tuberculosis
    Andrea Tania Cruz, Lydia T. Ong, Jeffrey R. Starke · 2011 · Academic Emergency Medicine
  21. Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants
    Stan L. Block, Julie S. Shepard, Hartley Garfield, Fang Xie, Linda Han, Peter M Dull, Igor V. Smolenov · 2015 · The Pediatric Infectious Disease Journal
  22. Genomic Analysis of Serogroup YNeisseria meningitidisIsolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms
    Neil J. Oldfield, Odile Barbara Harrison, Christopher D. Bayliss, Martin C. J. Maiden, Dlawer A. A. Ala’Aldeen, David P. J. Turner · 2016 · The Journal of Infectious Diseases
  23. Study of the Immune Response in the Elderly: Is It Necessary to Develop a Vaccine againstNeisseria meningitidisfor the Aged?
    Gabriela Trzewikoswki de Lima, Elizabeth De Gaspari · 2019 · Journal of Aging Research
  24. Invasive Meningococcal Disease in Childhood
    Anne F. Brayer, Sharon G. Humiston · 2011 · Pediatrics in Review
  25. From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood
    Andrew B. Janowski, Jason G. Newland · 2017 · F1000Research
  26. Costs of Sequelae Associated with Invasive Meningococcal Disease: Findings from a US Managed Care Population
    Sudeep J Karve, Derek A. Misurski, Jacqueline M. Miller, Keith L. Davis · 2011 · Health Outcomes Research in Medicine
  27. The safety profile of Haemophilus influenzae type b– Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)
    Stephen B. Rinderknecht, Kristina A. Bryant, Terry M. Nolan, Noris Pavía-Ruz, Carlos Aranza Doniz, Miguel Angel Rodriguez Weber, Christopher J. Cohen, Emmanuel Aris, Narcisa Elena Mesaros, Jacqueline M. Miller · 2012 · Human Vaccines & Immunotherapeutics
  28. Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review
    Soha Ghanem, Sara Hassan, Randa K. Saad, Ghassan S. Dbaibo · 2013 · Expert Opinion on Biological Therapy
  29. Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals—the example of serogroup B meningococcal infection
    E. David G. McIntosh, Victor Carey, Daniela Toneatto, Peter M Dull, James Wassil · 2014 · Therapeutic Advances in Vaccines
  30. Lessons learned and applied
    Corey Hebert, Corey M. Hall, La’ Nyia J. Odoms · 2012 · Human Vaccines & Immunotherapeutics
  31. Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™
    Michael L. Leonardi, Thomas Latiolais, Kwabena O. Sarpong, Michael W. Simon, Jerry D. Twiggs, Paul Lei, Stephen B. Rinderknecht, Mark M. Blatter, Véronique Bianco, Yaela Baine et al. · 2014 · Vaccine
  32. Distribution of Neisseria meningitidis serogroup b (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009–2014, prior to NmB vaccine licensure
    How-Yi Chang, Jeni T. Vuong, Fang Hu, Paul Liberator, Alex Chen, Cécilia B. Kretz, Amy E. Blain, Hao Li, Adam C. Retchless, Melissa J. Whaley et al. · 2019 · Journal of Infection
  33. Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents
    Timo Vesikari, Jerzy Brzostek, Anitta Ahonen, Marita Paassilta, Ewa Majda-Stanisławska, Leszek Szenborn, Miia Virta, Robert A. Clifford, Teresa Jackowska, Murray A. Kimmel et al. · 2021 · Human Vaccines & Immunotherapeutics
  34. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987–2013
    Entesar H. Husain, Mohammad Barakat, Mosaab Al-Saleh · 2015 · Journal of Infection and Public Health
  35. Practice Patterns of Infectious Disease Physicians for Management of Meningococcal Disease
    Andrew Terranella, Susan E. Beekmann, Philip M. Polgreen, Amanda C. Cohn, Henry M. Wu, Thomas A. Clark · 2012 · The Pediatric Infectious Disease Journal
  36. Estimating costs associated with a community outbreak of meningococcal disease in a colombian Caribbean city.
    Hernando Pinzón-Redondo, Wilfrido Coronell-Rodríguez, Inés Díaz-Martinez, Ángel Alfonso Guzmán-Corena, Dagna O. Constenla, Nelson Alvis‐Guzmán · 2014 · PubMed Central
  37. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
    Lee H. Harrison, Dan M. Granoff, Andrew John Pollard · 2017 · Elsevier eBooks
  38. Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis
    Philip H. C. Kremer, John A. Lees, Bart Ferwerda, Arie VAN DER ENDE, Matthijs C. Brouwer, Stephen D. Bentley, Diederik van de Beek · 2020 · Frontiers in Medicine
  39. Vaccines for Prevention of Group B Meningococcal Disease
    Lee H. Harrison · 2015 · American Journal of Preventive Medicine
  40. Bacterial Meningitis in Older Adults
    Diedre M. Hofinger, Larry Eugene Davis · 2013 · Current Treatment Options in Neurology
  41. Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT) Given at 12–15 Months of Age
    Gary S. Marshall, Mark M. Blatter, Colin D. Marchant, Emmanuel Aris, Narcisa Elena Mesaros, Jacqueline M. Miller · 2013 · The Pediatric Infectious Disease Journal
  42. Haemophilus influenzaetype b–Neisseria meningitidisserogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
    Kristina A. Bryant, Gary S. Marshall · 2011 · Expert Review of Vaccines
  43. A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine
    Kirsten P. Perrett, Terry M. Nolan, Jodie McVernon · 2013 · Infectious Diseases and Therapy
  44. Neisseria Base: a comparative genomics database for Neisseria meningitidis
    Lee S. Katz, Jay C. Humphrey, Andrew B. Conley, Viswateja Nelakuditi, Andrey O. Kislyuk, Sonia Agrawal, Pushkala Jayaraman, Brian H. Harcourt, Melissa A. Olsen-Rasmussen, Michael A. Frace et al. · 2011 · Database
  45. Meningococcal disease and vaccination in college students
    Sarah Schaffer DeRoo, Rachel G. Torres, Linda Y. Fu · 2021 · Human Vaccines & Immunotherapeutics
  46. Antibody persistence to meningococcal serogroups A, C, W and Y in toddlers two years after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate (MenACWY-TT) vaccine as measured by bactericidal antibody assays using rabbit or human complement
    Timo Vesikari, Aino Forstén, Véronique Bianco, Marie Van der Wielen, Jacqueline M. Miller · 2014 · Trials in Vaccinology
  47. Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
    Absatou Ky Ba, Idrissa Sanou, Paul A. Kristiansen, Sangaré Lassana, Rasmata Ouédraogo, Kalifa Ouattara, Maxime Kienou, Simon Tiendrébéogo, Juliette Tranchot‐Diallo · 2014 · BMC Infectious Diseases
  48. Immunogenicity and Safety of Combined Tetanus, Reduced Diphtheria, Acellular Pertussis Vaccine when Co-Administered with Quadrivalent Meningococcal Conjugate and Human Papillomavirus Vaccines in Healthy Adolescents
    William Johnston · 2014 · Journal of Vaccines & Vaccination
  49. MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults
    Mary E. Tipton, Wendy Daly, Shelly David Senders, Stanley L. Block, Maria Lattanzi, Thembile Mzolo, Silvia Barbi, Michele Pellegrini, Pavitra Keshavan · 2019 · Vaccine
  50. Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda
    Eddie Mujjwiga Wampande, Ezekiel Mupere, Devan Jaganath, Mary Nsereko, Harriet Mayanja‐Kizza, Kathleen Davis Eisenach, W. Henry Boom, Sébastien Gagneux, Moses Lutaakome Joloba · 2015 · BMC Pediatrics
  51. Inching Toward a Serogroup B Meningococcal Vaccine for Infants
    Amanda C. Cohn, Nancy E. Messonnier · 2012 · JAMA
  52. Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000–2005
    Ann E. Wiringa, Kathleen A. Shutt, Jane W. Marsh, Amanda C. Cohn, Nancy E. Messonnier, Shelley M. Zansky, Susan Petit, Monica M. Farley, Ken Gershman, Ruth Lynfield et al. · 2013 · PLoS ONE
  53. Innovations in Drug Delivery Strategies for Breast Cancer
    Mani Sharma, Rama Satya Sri Kotipalli, Nemala Siva Kumar, Abhiram Kumar, Mohini Rawat, Chhavi Dhiman, Madhaw Kumar · 2024 · IntechOpen eBooks
  54. Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes
    Alexander Domnich, Roberto Gasparini, Daniela Amicizia, Giuseppe Boccadifuoco, Marzia Monica Giuliani, Donatella Panatto · 2015 · Journal of Immunology Research
  55. Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix®): A Review
    Caroline M. Perry · 2013 · Drugs
  56. Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel
    Manisha Patel, Sandra Romero‐Steiner, Michael P. Broderick, Cynthia G. Thomas, Brian D. Plikaytis, Daniel S. Schmidt, Scott E. Johnson, Andrea Milton, George M. Carlone, Thomas A. Clark et al. · 2014 · Vaccine
  57. Advances in meningococcal vaccines
    Mariagrazia Pizza, Lisa M DeTora, James Wassil · 2012 · Clinical Practice
  58. Defining efficacy in meningococcal vaccine trials
    Paul B. Keiser, Christopher John Gill · 2012 · Clinical Investigation
  59. Bacterial Genomic Detection Within Cerebrospinal Fluid of Patients With Meningococcal Disease Is Influenced by Microbial and Host Characteristics
    Thomas C. Darton, Malcolm Guiver, Stacee Naylor, Edward B. Kaczmarski, Ray Borrow, Robert Charles Read · 2011 · Clinical Infectious Diseases
  60. Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
    Enrique Chacón‐Cruz, Erika Zoe Lopatynsky-Reyes, Gloria Isabel Huerta Prado, Maria Yolanda Cervantes-Apolinar, Adriana Guzmán-Holst, Desirée Van Oorschot · 2022 · Human Vaccines & Immunotherapeutics
  61. A Case of Meningococcal Pyomyositis in an Otherwise Healthy Adult
    Monique T. Barakat, Kiran Gajurel, Katrina A. Fischer, Kathryn J. Stevens, Errol Ozdalga, José Gilberto Montoya · 2016 · Open Forum Infectious Diseases
  62. U.S. Military Fatalities due toNeisseria meningitidis: Case Reports and Historical Perspective
    Paul B. Keiser, Lanette R. Hamilton, Michael P. Broderick · 2011 · Military Medicine
  63. Microbial epidemiology and carriage studies for the evaluation of vaccines
    Abigail L. Coughtrie, Johanna M. Jefferies, David William Cleary, Charles Patrick Doncaster, Saul N. Faust, Alex R. Kraaijeveld, Michael V Moore, Mark Mullee, Paul J. Roderick, Jeremy Stephen Webb et al. · 2019 · Journal of Medical Microbiology
  64. The epidemiology of invasive meningococcal disease and the utility of vaccination in Malta
    David Pace, Charmaine Gauci, Christopher Barbara · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
  65. Predictors of meningococcal vaccine uptake in university and college students: a systematic review and meta-analysis
    Joanna L Whisnant, Jacqueline Martin‐Kerry, Lydia Flett, Peter Knapp · 2020 · Journal of American College Health
  66. Right to health for children
    R. N. Srivastava · 2015 · Indian Pediatrics
  67. The early clinical development of a multicomponent vaccine against meningococcal serogroup B
    James Wassil, E. David G. McIntosh, Davide Serruto, Lisa M DeTora, Michael Bröker, ALAN E. KIMURA · 2012 · Clinical Investigation
  68. Prevention of Meningococcal Infections in the First 2 Years of Life
    Charles Reece Woods · 2013 · Pediatric Annals
  69. Immunogenicity of the meningococcal polysaccharide conjugate vaccine in pediatric kidney transplant patients
    Delphine R. Nelson, Jeffrey J. Fadrowski, Alicia M. Neu · 2018 · Pediatric Nephrology
  70. Current status and challenges in the care of patients with bacterial meningitis in the Philippines: A scoping review
    Ferron F. Ocampo, Adrian Isidoro Espiritu, Roland Dominic G. Jamora · 2021 · Tropical Medicine & International Health
  71. Bacterial Meningitis in Childhood
    Manish Sadarangani, Andrew John Pollard · 2011 · Advances in experimental medicine and biology
  72. Analytical Challenges in Novel Pentavalent Meningococcal Conjugate Vaccine (A, C, Y, W, X)
    Pankaj Losan Sharma, Sameer Kale, Swapnil Phugare, Sunil Kumar Goel, Sunil Gairola · 2024 · Vaccines
  73. Completeness ofNeisseria meningitidisreporting in New York City, 1989–2010
    Lola S. Arakaki, Stephanie Ngai, Don Weiss · 2016 · Epidemiology and Infection
  74. Differences in the courses of meningococcal and pneumococcal cerebrospinal meningitis
    W Szymański, Krzysztof Adam Simon, Marta Rorat · 2020 · Neurologia i Neurochirurgia Polska
  75. Engineering a novel multi-epitope mRNA vaccine against major bacterial meningitis pathogens: E. coli K1, Group B Streptococcus, Listeria monocytogenes, Neisseria meningitidis, and Streptococcus pneumoniae
    Nasim Fattahi, Saeed Khoshnood, Nazanin Omidi, Behrooz Sadeghi Kalani · 2025 · International Journal of Biological Macromolecules
  76. Surveillance for Neisseria meningitidis Disease Activity and Transmission Using Information Technology
    Sohail Ahmed, Ernesto Oviedo‐Orta, Sumiko R. Mekaru, Clark C. Freifeld, Gervais H. Tougas, John S. Brownstein · 2015 · PLoS ONE
  77. Meningococcal Disease: Shifting Epidemiology and Genetic Mechanisms That May Contribute to Serogroup C Virulence
    Jessica R. MacNeil, Jennifer Dolan Thomas, Amanda C. Cohn · 2011 · Current Infectious Disease Reports
  78. Lymphocyte apoptosis in children with central nervous system tuberculosis: a case control study
    Paola Di Carlo, Alessandra Casuccio, Amelia Romano, Daria Spicola, Lucina Titone, Nadia Caccamo, Francesco Dieli, Caterina Mammina, Elisabetta Pace, Mark Gjomarkaj et al. · 2011 · BMC Pediatrics
  79. Meningococcal disease serogroup C
    Félix Dickinson, Cuevas, Antonio E. Pérez · 2012 · Risk Management and Healthcare Policy
  80. The AmiC/NlpD Pathway Dominates Peptidoglycan Breakdown in Neisseria meningitidis and Affects Cell Separation, NOD1 Agonist Production, and Infection
    Jia Mun Chan, Kathleen T. Hackett, Katelynn L. Woodhams, Ryan E. Schaub, Joseph P. Dillard · 2022 · Infection and Immunity
  81. Estimates of the burden of meningococcal disease in Italy: implications for prevention and control
    Domenico Martinelli, Francesca Fortunato, Rosa Prato · 2015 · Journal of preventive medicine and hygiene
  82. Timing of Adolescent Meningococcal Conjugate Vaccination
    Mandy Atlee Allison, Amanda C. Cohn, Shannon K. Stokley, Lori A. Crane, Sean T. O’Leary, Laura P. Hurley, Christine I. Babbel, Fran Dong, Claire Gahm, Jonathan L. Temte et al. · 2011 · American Journal of Preventive Medicine
  83. Introduction and epidemiology of meningococcal disease
    Caroline L. Trotter, Mary Elizabeth Ramsay, Lee H. Harrison · 2016 · Springer eBooks
  84. Distinct evolutionary patterns of Neisseria meningitidis serogroup B disease outbreaks at two universities in the USA
    Hao Li, Matthew T. G. Holden, Xin Wang, Lubomira Andrew, Sabine Wellnitz, Fang Hu, Melissa J. Whaley, Scott R. Sammons, Kristen M. Knipe, Mike Frace et al. · 2018 · Microbial Genomics
  85. Global epidemiology of serogroup Y invasive meningococcal disease: a literature review
    Myint Tin Tin Htar, Jamie Findlow, Paul Balmer, David L. Swerdlow · 2024 · Epidemiology and Infection
  86. Antibiotic Resistance in Neisseria
    Margaret C. Bash, Durrie L. McKnew, JOHN W. TAPSALL · 2009 · Humana Press eBooks
  87. Dissemination of the ST-103 clonal complex serogroup C meningococci in Salvador, Brazil
    Soraia Machado Cordeiro, Cristiane Wanderley Cardoso, Lorena Galvão de Araújo, Luís Eduardo Ribeiro, Jailton Azevedo, Rita de Cássia Vilasboas Silva, Mitermayer Galvão dos Reis, Albert Icksang Ko, Joice Neves Reis Pedreira · 2017 · Microbes and Infection
  88. How to inform college students about meningitis B vaccine? Comparative effectiveness of an online theory-based text and video intervention
    Heba A. T. Aref, Salisa C. Westrick, Chiahung Chou, Debra L. Worthington, Kimberly B. Garza · 2022 · Journal of American College Health
  89. Secular trends in invasive meningococcal disease, Massachusetts, 1988–2011: what happened to invasive disease?
    Anne Harwood Peruski, Patricia Kludt, R. S. PATEL, Alfred DeMaria · 2014 · Epidemiology and Infection
  90. Meningococcal pneumonia in Japan: A case report and literature review
    Jun Hirai, Takeshi Kinjo, Takaaki Tome, Mao Hagihara, Daisuke Sakanashi, Hideta Nakamura, Shusaku Haranaga, Hiroshige Mikamo, Jiro Fujita · 2016 · Journal of Infection and Chemotherapy
  91. Analysis of the impact of corticosteroids adjuvant treatment during experimental invasive meningococcal infection in mice
    Michaël Levy, Ala‐Eddine Deghmane, Myriam Aouiti-Trabelsi, Stéphane Dauger, Albert Faye, Patricia Mariani‐Kurkdjian, Muhamed‐Kheir Taha · 2018 · Steroids
  92. Estimation of the Potential Benefits of Meningococcal Vaccination in Children at 9 and 12 Months of Age Using a Predictive Mathematical Model
    Nikolay Ivanovich Briko, O. I. Volkova, I. S. Korolyova, Курилович Екатерина Олеговна, L. D. Popovich, И В Фельдблюм · 2020 · Epidemiology and Vaccinal Prevention
  93. Características clínicas y factores pronósticos de la enfermedad meningocóccica: un estudio de serie de casos en Chile durante el brote 2012-2013
    Isabel Matute, Andrea Olea N, Darío López, Sergio Loayza, Manuel Nájera, Claudia González, Lucy Poffald, Macarena Hirmas, Iris Delgado, Elena Pedroni et al. · 2015 · Revista chilena de infectología
  94. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018
    Maria Koliou, Diamanto Kasapi, Stella Mazeri, Panagiota Maikanti-Charalampous, Anna Demetriou, Chrystalla Skordi, Maria Agathocleous, Georgina Tzanakaki, Elisavet Constantinou · 2020 · Eurosurveillance
  95. On the Trail of Preventing Meningococcal Disease: A Survey of Students Planning to Travel to the United States
    Hsien‐Liang Huang, Shao‐Yi Cheng, Long‐Teng Lee, Chien‐An Yao, Chia‐Wei Chu, Chia‐Wen Lu, Tai‐Yuan Chiu, Kuo‐Chin Huang · 2013 · Journal of Travel Medicine
  96. The difficult road to new vaccines for pertussis and serogroup B meningococcal disease
    Andrew R. GORRINGE · 2015 · Journal of Chemical Technology & Biotechnology
  97. MenHibrix
    Sarah Fetterman Hale, Lauren Camaione, Ben M. Lomaestro · 2013 · Annals of Pharmacotherapy
  98. Acute and chronic bacterial infections and sarcoidosis
    Nikolaus Deigendesch, Werner Stenzel · 2017 · Handbook of clinical neurology
  99. Epidemiology of invasive meningococcal disease in the United States: review of recent data and identified risk factors
    Jessica Vespa Presa, Daniel Spitz, Paul Balmer, Vincenza T. Snow, Kathleen L. Dooling · 2026 · Frontiers in Public Health
  100. Meningococcal carriage and transmission dynamics in college students in Louisville, Kentucky
    Forest Wayne Arnold, Leslie A. Wolf, Subathra Marimuthu, Jamie Findlow, Angela Quinn, Vidyulata Salunkhe, Daniya Sheikh, Phillip F. Bressoud, T’shura Ali, Dawn Balcom et al. · 2026 · PLoS ONE